FORMULATION
植物配方
Botanical formulation
從植物來源、配方研究到營養支持，了解產品的研發脈絡。
Explore the development of the botanical formula and its nutritional role.
認識配方About the formulation
Dibifree180®
抗糖新觀念
從植物營養出發，照顧每天的飲食與生活。
Rethinking glucose care
Botanical nutrition for everyday meals and care.
植物營養 · 442 飲食指導 · 180 天陪伴Botanical nutrition · 442 food guidance · 180 days
LIGHTAIRWATERPLANT
0102
抗糖新觀念
Glucose support
從植物原料的研究，到三餐與 180 天的個別陪伴。
From botanical research to meals and 180 days of individual support.
減重智取勝
Weight support
從減重到長期維持，提前規劃營養與生活支持。
Plan nutrition and daily-life support for long-term weight care.
從配方，到生活。
From formulation to everyday life.
BOTANICAL NUTRITION · EVERYDAY CARE
Dibifree180®，讓營養有方向。
Dibifree180®. A starting point for nutrition.
每天怎麼吃、如何記錄、遇到問題和誰討論，都是照護的一部分。
Meals, daily records and someone to turn to: each has a place in everyday care.
從植物配方到 442 飲食指導，再到持續回饋，Dibifree180® 把營養支持連回生活。
Dibifree180® connects its botanical formula with 442 food guidance and ongoing feedback.
認識基諾華Meet GeninovaPUBLICATION
國際期刊
International publication
研究發表於 Food Research International，可直接查閱原文與研究設計。
Read the study published in Food Research International and examine its design.
閱讀論文Read the publicationHUMAN STUDY
人體研究
Human study
40 位第二型糖尿病成人參與，觀察血糖及體重相關指標。
Forty adults with type 2 diabetes participated, with glucose and weight-related outcomes assessed.
了解研究設計Explore the study design研究期程為 7 個月，與 180 天服務安排分開呈現；個別結果請依研究條件理解。
The study lasted seven months and is presented separately from the 180-day service. Interpret individual outcomes within the study context.
Food Research International · 223 (2026) 117820 ↗
180 天，走進日常。
180 days of everyday care.
先記住 442：纖維、蛋白、好油。
Start with 442: fibre, protein and good oils.
依公司 442 方針，不納入澱粉類食物；實際份量由衛教團隊協助確認。
The company’s 442 approach excludes starchy foods. Confirm individual portions with the education team.
膳食纖維
Dietary fibre
纖維蔬菜
Fibrous vegetables
優質蛋白質
Quality protein
魚・肉・豆・蛋
Fish · meat · beans · eggs
好油
Good oils
橄欖油・酪梨油・苦茶油
Olive · avocado · tea seed oil
- 起點START
一起了解你
Understand your starting point
整理現有檢驗、用藥、平日餐食與目標，先了解你的生活。
Review current results, medicines, meals and personal goals.
- 每天DAILY
記錄，也有回饋
Record and receive feedback
依個人安排留下餐照、血糖與體重紀錄，和團隊討論實際困難。
Record meals, glucose and weight as individually arranged, and discuss practical difficulties.
- 第 30 天DAY 30
回看第一個月
Review the first month
回顧餐食、紀錄與生活變化，一起調整接下來的做法。
Review food choices, records and daily-life changes, then adjust the next steps.
- 第 180 天DAY 180
看進度，也看下一步
Review progress and plan ahead
整理這段時間的紀錄與檢驗，討論下一階段如何維持。
Review the accumulated records and results, and discuss the next stage.
這是服務流程介紹；個別項目與回饋頻率於諮詢時確認。
This outlines the service journey. Confirm individual services and feedback frequency during consultation.
看減糖衛教與飲食安排Explore glucose education and meals看減重第一個月如何開始Explore the first month of weight support每段經歷，都有生活的樣子。
The everyday stories behind the journey.
從不愛運動，到有人陪著持續。
From avoiding exercise to finding a routine.
衛教課程、跑步機與雲端回報，慢慢成為日常的一部分。
Education sessions, treadmill activity and online feedback gradually became part of daily life.
糖友見證集第七版・第 25 頁
Seventh-edition accounts · p.25
閱讀這段經歷Read the account聚餐的壓力，可以一起面對。
Support through social-meal pressure.
有家人備餐與同伴鼓勵，也有朋友勸吃的困難。餐食調整，需要生活裡的支持。
Family meal preparation and peer encouragement offered support, alongside the challenges of eating socially.
第二型糖尿病個案的體重管理經驗・第 23–24 頁
Weight-management experience in type 2 diabetes · pp.23–24
閱讀這段經歷Read the account見證呈現飲食、活動與其他照護共同參與的個人經驗，不能單獨證明產品效果。
These personal accounts include changes in diet, activity and other care; they do not independently establish product effects.
從你的需要，找到下一步。
Find your next step.
糖友與購買者
Individuals & purchasers
了解 Dibifree180®、方案內容與開始方式。
Learn about Dibifree180®, the program and how to begin.
網紅與內容創作者
Creators & influencers
分享你的平台、受眾與內容合作想法。
Share your platform, audience and content ideas.
經銷商與代理商
Distributors & agents
說明所在市場與服務對象，討論合作。
Tell us your market and audience to explore a partnership.
志願者與社群支持
Volunteers & communities
留下希望參與的方式與可投入的時間。
Tell us how you would like to contribute and your availability.
需要更進一步了解個人差異？
Want to explore individual differences further?
基因檢測為公司的延伸服務，依需求諮詢後，再討論適用的評估方式。
Genetic testing is an additional company service. Discuss your needs before considering an assessment.
如有癌症輔療基因檢測諮詢需求，請與我們個別聯絡。
For cancer-support genetic testing inquiries, please contact us individually.
個別聯絡Contact usGENINOVA · OUR STORY
研究植物，
讓科學走進
日常生活。
基諾華以植物藥研究為根基，連結配方開發、人體研究與個人化健康服務。
Rooted in plants.
Focused on people.
Geninova connects botanical medicine research with formulation development, human studies and personalized health services.
RESEARCH INTO EVERYDAY CARE
從研究出發，
把照護帶進生活。
串起植物研究、配方開發與專業判讀，讓營養支持與健康紀錄回到每個人的日常。
From research to everyday care.
We bring botanical research, formulation development and professional interpretation into everyday nutrition and health records.
BOTANICAL NUTRITION
植物營養，走進生活。
Botanical nutrition for everyday life.
Dibifree180® 連結植物配方、飲食指導與持續陪伴。從每天的一餐、一份紀錄，建立適合自己的照護節奏。
Dibifree180® brings together botanical nutrition, food guidance and ongoing support. Build your care routine, one meal and one record at a time.
- Dibifree180®植物配方Botanical formulation
- 442飲食指導Food guidance
- 180天持續陪伴Days of support
NATURE, STUDIED WITH RIGOR.
尊重自然，也尊重證據。
從植物來源、活性成分到人體研究，讓研發的每一步都有跡可循。
Respecting nature and evidence.
From plant origins and active compounds to human studies, research should remain traceable at every step.
OUR BRAND
You have better choices.
You have better choices.
把植物研究帶進產品開發，讓人們更了解日常營養的選擇。
Bringing botanical research into product development, and making everyday nutritional choices easier to understand.
公司原有跨產品宣傳圖。Dibifree180® 的人體研究與適用範圍，請見科研證據；營養補充不作為處方藥或疫苗的替代。
Original cross-product brand artwork. See Science for the Dibifree180® human study and its scope. Nutritional supplementation does not replace prescribed medication or vaccination.
PUBLIC MILESTONES
研發有歷程，證據可追溯。
從研究完成、公開登記到論文發表，查閱各階段的來源與紀錄。
A research journey you can trace.
Follow the sources and records, from study completion and registration to publication.
人體研究完成結案與解盲
公司研究資料記載完成隨機雙盲研究與解盲；後續正式論文公開研究設計與分析結果。
Human study completed and unblinded
Company records document study completion; the later peer-reviewed paper reports its design and analysis.
Virofree 研究發表
計算研究連接細胞與生化驗證，刊於 Frontiers in Pharmacology。
Virofree research published
Computational work connected with cellular and biochemical validation in Frontiers in Pharmacology.
Dibifree 研究公開登記
研究設計、觀察指標與登記歷程公開於 ClinicalTrials.gov。
Dibifree trial registered
The study design, outcomes and record history are public on ClinicalTrials.gov.
隨機對照研究正式刊載
40人分析結果刊於 Food Research International 223，並收錄於 PubMed。
Randomized controlled study published
The 40-participant analysis appeared in Food Research International 223 and is indexed in PubMed.
02 · CORE PLATFORM
精準測量之後，
真正重要的是
如何行動。
個人精準健康風險地圖＋180天個人化管理＋年度健康長壽服務。
After precision measurement,
what matters is
how we act.
A personal precision health map, a 180-day management plan and ongoing longevity support.
THE HEALTH LOOP
從生命數據到持續改善的完整閉環
A complete loop from life data to continuous improvement
THREE CONNECTED LAYERS
數據與判讀層
整合適用的基因、臨床生物標誌、體組成、生活方式與用藥資訊，建立個人風險與管理優先序。
Data & Interpretation
Integrate relevant genetics, clinical biomarkers, body composition, lifestyle and medication data to define personal risk and priorities.
個人化干預層
把判讀轉化為可執行的藥物建議、保健食品建議、植物營養、飲食、運動與睡眠方案；藥物須由醫師評估，保健食品則由專業團隊依用藥與個人風險共同確認。
Personalized Intervention
Translate insights into actionable medication guidance, health-food and supplement guidance, botanical nutrition, diet, movement and sleep plans. Medication decisions require physician review, while supplement use is checked by the professional team against medications and individual risks.
持續服務與交付層
透過AI輔助追蹤、90／180天復評與年度會員服務，累積真實變化並優化下一階段。
Longitudinal Delivery
Use AI-assisted follow-up, 90/180-day reassessment and annual services to learn from real change and refine the next stage.
CARE IN EVERYDAY LIFE
讓照護回到生活。
Make care part of everyday life.
從植物營養、個人健康紀錄到專業討論，把每天的飲食、活動與追蹤連在一起。數據幫助理解變化，服務回到每個人的生活與目標。
Connect botanical nutrition, personal records and professional conversations with meals, activity and follow-up. Use data to understand change and shape care around each person’s life and goals.
- 植物營養Botanical nutrition
- 健康紀錄Health records
- 個人化照護Personalized care
- 持續回饋Ongoing feedback
依需求選擇基因服務
Find a genomic service
GENINOVA GENOMIC SERVICES
基因檢測不只找出差異，
更要讓結果成為
可以採取的下一步。
基因檢測是 Dibifree180® 營養干預之外的個別評估服務，依糖尿／減糖、減重與免疫相關需求，討論適合的檢測與後續判讀。
Genomic testing should do more than identify differences.
It should inform
the next decision.
Genomic testing is a separate assessment service alongside Dibifree180® nutritional intervention, addressing glucose, weight and immune-related questions through individual consultation.
05 · END-TO-END GENOMICS
全鏈式基因檢測服務
從需求定義到結果交付，一條服務鏈完成，不把客戶留在只有原始數據的階段。
依個人健康、醫療、研究或產品開發情境，由基諾華團隊規劃適合的檢體與技術路徑，完成品質確認、定序、生物資訊分析、結果註釋與專業報告，並可銜接後續生命數據管理。
End-to-End Genomic Testing
One connected workflow from defining the question to delivering an interpretable result.
For personal health, clinical, research or product-development needs, the Geninova team plans the specimen and technical pathway, performs quality review, sequencing, bioinformatics, annotation and professional reporting, with optional integration into longitudinal health-data management.
- 01需求與檢體規劃釐清使用情境、樣本條件與分析目標Scope & specimenDefine context, specimen conditions and analytical goals
- 02實驗與品質流程核酸處理、品質確認與適用定序流程Laboratory & qualityNucleic-acid preparation, quality review and suitable sequencing
- 03生物資訊分析資料處理、變異辨識、註釋與品質檢查BioinformaticsData processing, variant calling, annotation and quality checks
- 04報告與後續整合專業報告、溝通支援與長期資料銜接Report & integrationProfessional reporting, communication support and longitudinal integration
ONE IN-HOUSE WORKFLOW
不是只交付一份檢測結果，而是把問題、數據與決策連起來。
客戶直接與基諾華團隊討論需求；同一服務流程負責專案設計、檢體條件、分析邏輯、報告內容及後續應用溝通。
We connect the question, the data and the decision.
Clients work directly with the Geninova team across project design, specimen requirements, analytical logic, report content and follow-through.
GENINOVA FULL-SERVICE SOP
從第一次諮詢，到90／180天復評。
From the first inquiry to 90/180-day reassessment.
客戶不必自行協調不同單位。業務、服務人員、護理師、醫師、實驗室與產品團隊依同一案件進度接力，每一步都有負責角色、交付成果與下一個明確動作。
Clients do not need to coordinate separate providers. Business, service, nursing, physician, laboratory and product teams work from one case pathway, with a clear owner, deliverable and next action at every step.
01接案與評估Intake & assessment
02採檢與分析Collection & analysis
03判讀與交付Review & delivery
04持續追蹤Ongoing follow-up
01服務入口ENTRY
客戶諮詢
負責角色｜客戶服務
- 客戶取得
- 需求確認與諮詢編號
- 下一步
- 補充基本需求與聯絡方式
- 參考時程
- 起始日
Client inquiry
Owner | Client service
- Deliverable
- Inquiry record and case number
- Next
- Confirm needs and contact details
- Timing
- Starting day
02單一窗口ONE CONTACT
專人接案
負責角色｜業務、服務經理
- 客戶取得
- 服務方向與所需資料清單
- 下一步
- 安排醫師初評
- 參考時程
- 諮詢後1–2個工作日
Case assignment
Owner | Business & service manager
- Deliverable
- Service direction and information checklist
- Next
- Schedule physician assessment
- Timing
- 1–2 business days after inquiry
03臨床入口CLINICAL GATE
醫師初評
負責角色｜醫師
- 客戶取得
- 適用性評估與檢測方向
- 下一步
- 確認檢體、方案與必要轉介
- 參考時程
- 依門診或線上評估安排
Physician assessment
Owner | Physician
- Deliverable
- Suitability review and testing direction
- Next
- Confirm specimen, plan and referral needs
- Timing
- By clinic or online assessment schedule
04服務協調COORDINATION
護理／服務安排
負責角色｜護理師、服務專員
- 客戶取得
- 預約、採檢說明與行前準備
- 下一步
- 依預約完成採檢
- 參考時程
- 初評完成後安排
Care coordination
Owner | Nurse & service coordinator
- Deliverable
- Appointment and collection instructions
- Next
- Complete scheduled collection
- Timing
- Arranged after assessment
05品質關卡QUALITY GATE
採檢與品質確認
負責角色｜護理師、實驗室
- 客戶取得
- 檢體收件與品質狀態
- 下一步
- 合格檢體進入定序流程
- 參考時程
- 預約採檢日
Collection & quality
Owner | Nurse & laboratory
- Deliverable
- Specimen receipt and quality status
- Next
- Qualified specimen enters sequencing
- Timing
- Scheduled collection day
06實驗與數據LAB & DATA
基因定序與分析
負責角色｜實驗室、生物資訊團隊
- 客戶取得
- 品質控管後的變異分析資料
- 下一步
- 提交醫師與專業團隊判讀
- 參考時程
- 依檢體與檢測方案確認
Sequencing & analysis
Owner | Laboratory & bioinformatics
- Deliverable
- Quality-controlled variant analysis
- Next
- Professional and physician review
- Timing
- Confirmed by specimen and test plan
07專業判讀PROFESSIONAL REVIEW
醫師判讀報告
負責角色｜醫師、專業團隊
- 客戶取得
- 正式報告、重點解讀與限制說明
- 下一步
- 討論可執行的健康管理方向
- 參考時程
- 分析完成後安排
Physician report review
Owner | Physician & professional team
- Deliverable
- Report, key interpretation and limitations
- Next
- Discuss actionable management direction
- Timing
- Scheduled after analysis
08個人化設計PERSONALIZATION
客製化方案或商品
負責角色｜醫師、產品團隊
- 客戶取得
- 藥物建議、保健食品建議與其他個人化方案
- 下一步
- 確認內容、使用方式與追蹤指標
- 參考時程
- 完成判讀後共同確認
Personalized plan or product
Owner | Physician & product team
- Deliverable
- Medication guidance, supplement guidance and other suitable support
- Next
- Confirm use and tracking indicators
- Timing
- Agreed after professional review
09正式啟動ACTIVATION
交付與使用指導
負責角色｜服務專員、護理師
- 客戶取得
- 方案內容、使用指導與追蹤計畫
- 下一步
- 開始執行並記錄反應
- 參考時程
- 方案確認後啟動
Delivery & guidance
Owner | Service coordinator & nurse
- Deliverable
- Plan, usage guidance and follow-up schedule
- Next
- Begin and record response
- Timing
- Starts after plan confirmation
10健康閉環HEALTH LOOP
持續追蹤與復評
負責角色｜醫師、護理師、服務團隊
- 客戶取得
- 90／180天進度、指標與調整建議
- 下一步
- 更新下一階段方案
- 參考時程
- 90天追蹤・180天復評
Follow-up & reassessment
Owner | Physician, nurse & service team
- Deliverable
- 90/180-day progress and adjustment review
- Next
- Update the next-stage plan
- Timing
- Day 90 follow-up · Day 180 review
DAY 90追蹤執行情況、反應與指標變化Review execution, response and indicator changesDAY 180完整復評，更新下一階段方案Reassess and update the next-stage plan
實際服務內容、角色配置與時程依個案、檢體、方案及適用規範確認。個人化商品或方案須經專業評估，不以單一基因結果直接決定。
Service scope, roles and timing depend on the case, specimen, selected plan and applicable requirements. A personalized product or plan requires professional assessment and is not determined by a genetic result alone.
實際檢測範圍、檢體類型、時程與報告內容，將依服務方案、檢體品質、適用法規及專業評估確認。癌症基因結果需由合格醫療專業人員結合病理與臨床資訊判讀，不單獨構成診斷或治療決策。
Scope, specimen type, turnaround time and report content depend on the selected service, specimen quality, applicable regulations and professional review. Cancer genomic results must be interpreted by qualified healthcare professionals with pathology and clinical information and do not independently constitute a diagnosis or treatment decision.
03 · SCIENCE
實證醫學
從機制、生物資訊到人體研究，基諾華持續建立可以公開檢視的證據鏈。
Evidence-based medicine
From mechanisms and bioinformatics to human studies, Geninova builds an evidence chain that can be examined openly.
從研究設計，看懂實證。
Understand the evidence through the study design.
DOI: 10.1016/j.foodres.2025.117820 ↗
OPEN ACCESS · 2026FOOD RESEARCH INTERNATIONAL · 223 (2026) 117820
Dibifree 人體隨機對照研究
40名第二型糖尿病成人參與7個月隨機、雙盲、安慰劑對照交叉研究；研究中的Dibifree作為既有治療的加成性膳食介入。
研究結果應依原始論文與個人醫療情況解讀，不代表疾病治療核准或個人效果保證。
Dibifree randomized controlled human study
Forty adults with type 2 diabetes participated in a seven-month randomized, double-blind, placebo-controlled crossover study. Dibifree was evaluated as an add-on dietary intervention to existing therapy.
Results should be interpreted with the original paper and individual medical context. They do not constitute treatment approval or a guarantee of personal outcomes.
READING THE EVIDENCE
研究看到了什麼？
What did the study observe?
3 MONTHS
血糖與糖化血色素
Glucose and HbA1c
論文報告三個月時，空腹血糖與 HbA1c 的組間改善；研究期間原有降糖藥維持不變。
The paper reports between-group improvements in fasting glucose and HbA1c at three months, with existing glucose-lowering medicines maintained.
7 MONTHS
體重與體組成指標
Weight-related outcomes
七個月研究報告體重、BMI 與估算體脂的組間差異。研究對象為第二型糖尿病成人。
The seven-month study reports between-group differences in weight, BMI and estimated body fat in adults with type 2 diabetes.
MECHANISMS
從機制到人體，分層閱讀
Read mechanisms and human results separately
論文也包含細胞與動物實驗，探索 GLP-1 等相關路徑；這些機制結果不等於與 GLP-1 藥物併用的臨床驗證。
Cell and animal experiments also explore pathways including GLP-1. These mechanistic findings do not establish clinical effects of co-use with GLP-1 medicines.
這是一項 40 人的小型研究。研究結果與個人見證應分開理解；不能直接推論為所有減重族群的效果，也不能作為一個月減重公斤數的保證。
This small study enrolled 40 people. Study results and personal accounts should be read separately; the findings cannot directly establish outcomes for all weight-management populations or guarantee a one-month weight change.
Food Research International · 223 (2026) 117820 · DOI: 10.1016/j.foodres.2025.117820 ↗
植物與配方研究
植物來源、活性成分與配方邏輯。
Plants & Formulation
Sources, active compounds and formulation rationale.
機制與生物資訊
路徑分析、功能實驗與研究假設。
Mechanism & Bioinformatics
Pathway analysis, functional assays and research hypotheses.
人體研究
規範研究、安全觀察與相關指標。
Human Research
Structured studies, safety observation and relevant outcomes.
產品與服務轉化
把證據轉化為可執行的健康支持。
Translation
Turn evidence into practical health support.
TWO EVIDENCE TRACKS
兩條證據鏈，證明基諾華具備跨層級研發能力。
研究從計算與機制假設出發，接續實驗驗證或人體研究。不同層級回答不同問題，也各自保留應有的應用邊界。
Two evidence tracks demonstrate research across multiple levels.
Work begins with computational and mechanistic hypotheses, then advances through experimental validation or human studies. Each level answers a different question and keeps an appropriate boundary for use.
計算研究與實驗驗證
以基因表達特徵及資料庫匹配提出候選方向，再以細胞與生化方法進一步驗證，相關成果於國際期刊發表。
Computational and experimental validation
Gene-expression signatures and database matching generated candidate directions, followed by cellular and biochemical validation and international publication.
- 基因表達特徵
- 計算匹配
- 細胞與生化驗證
人體研究與多路徑分析
研究涵蓋隨機、雙盲、安慰劑對照交叉設計，並結合轉錄體及功能實驗分析相關作用路徑。
Human study and multi-pathway analysis
The program includes a randomized, double-blind, placebo-controlled crossover study together with transcriptomic and functional analyses.
- ClinicalTrials.gov 公開登記
- 40人論文分析樣本
- Food Research International 同儕審查
研究證據用於說明公司的研發與轉化能力。個人健康應用仍需依研究層級、法規要求及專業醫療判斷進行。
Research evidence demonstrates Geninova's R&D and translation capabilities. Individual health applications remain subject to evidence level, regulation and professional clinical judgment.
05 · FOR CLINICIANS
讓數據、證據與
照護流程
真正接得起來。
為醫師、營養師、藥師、健檢與研究團隊提供研究資料、專業判讀與合作入口。
Connect data, evidence
and care
in practice.
A professional gateway for clinicians, dietitians, pharmacists, screening centers and research teams.
CLINICAL COLLABORATION
以專業判讀為核心的合作流程
A collaboration pathway centered on professional interpretation
資料整合
依個案與服務情境，整合適用的基因、臨床指標、生活方式、用藥與病史資訊。
Data integration
Combine relevant genetics, clinical markers, lifestyle, medication and history for the care context.
專業判讀
辨識風險、限制與管理優先序，讓報告成為可討論、可採取行動的依據。
Professional interpretation
Identify risk, limitations and priorities so reports can support informed, practical decisions.
干預與轉介
依專業角色共同規劃適當的營養、生活方式、植物方案、醫療追蹤或必要轉介。
Intervention and referral
Coordinate suitable nutrition, lifestyle, botanical support, clinical follow-up or referral.
追蹤與復評
以90／180天節點回看依從性、指標與反應，作為下一階段調整依據。
Follow-up and reassessment
Review adherence, markers and response at 90/180 days to guide the next stage.
EVIDENCE ACCESS
直接查看公開研究資料
相關人體研究已具公開試驗登記及同儕審查論文。合作評估應以完整研究資料、適用情境及個案條件為準。
Review the public evidence directly
Relevant human research includes public trial registration and a peer-reviewed paper. Collaboration decisions should consider the complete study, use context and patient factors.
06 · PARTNERSHIPS
共同建立一套
可以落地的
精準健康服務。
基諾華位在合作網絡的中樞，把生命數據轉成科研判讀，再接到個人化照護與可追蹤成果。
Build a precision health service
that works
in the real world.
Geninova sits at the center of the partner network, connecting life data with scientific interpretation, personalized care and measurable outcomes.
GENINOVA精準生命健康平台PRECISION HEALTH PLATFORM
DATA生命數據Life data
SCIENCE實證醫學Evidence
CARE個人化管理Personalized care
IMPACT追蹤成果Measured outcomes
資料進入平台後，經專業判讀形成方案；90／180天結果再回到模型，持續更新下一階段。
Data enters the platform, becomes an interpreted plan, and returns through 90/180-day outcomes to improve the next stage.
臨床照護合作
Clinical care collaboration
與醫療院所、診所及健康管理中心，共同討論營養介入、衛教、適用的數據追蹤與照護銜接。
Work with hospitals, clinics and health centers to plan nutritional support, education, relevant tracking and care coordination.
洽談合作Discuss collaborationAI 平台合作
AI platform collaboration
以 AI Metabolic OS／AI Health Twin 為合作方向，評估資料整合、專業判讀、服務流程及模組授權的需求。
Explore AI Metabolic OS / AI Health Twin collaboration, assessing data integration, professional interpretation, service workflows and module licensing.
洽談合作Discuss collaboration市場代理合作
Market and distribution
以 Dibifree180® 產品、營養衛教與持續服務為核心，依各地市場與服務對象規劃經銷或代理合作。
Build distribution partnerships around Dibifree180®, nutritional education and ongoing service, adapted to the market and audience.
洽談合作Discuss collaboration整合健康服務
Integrated health programs
與企業健康、健康管理及生活服務夥伴，討論會員陪伴、飲食支持、長期追蹤及跨團隊分工。
Co-design member support, nutrition programs, follow-up and team responsibilities with workplace wellness, health-management and lifestyle partners.
洽談合作Discuss collaborationGLOBAL CREATOR COLLABORATION
把真實經驗，變成有用的內容。
Turn real experiences into useful content.
歡迎分享 GLP-1 使用歷程、體重管理或營養生活的創作者，與我們一起把配方資訊、日常紀錄和研究說清楚。
We welcome creators covering GLP-1 journeys, weight management and everyday nutrition to explore collaboration on clear formulation information, daily records and research.
合作從你的受眾、市場與內容構想開始。內容審閱、合作揭露與成效追蹤方式，在洽談時共同確認。
Start with your audience, market and content ideas. Discuss editorial review, sponsorship disclosure and campaign measurement together.
提出創作者合作Propose a creator collaboration生活怎麼記
Document everyday life
餐食、活動與個人感受，呈現真實經驗與同期照護背景。
Share meals, activity and personal experiences together with the context of ongoing care.
配方怎麼看
Understand the formulation
對照產品資料與原始研究，分清原料、整體配方及人體研究。
Compare product information with original research, distinguishing ingredients, the complete formula and human studies.
問題怎麼問
Prepare better questions
把營養與用藥疑問帶進專業討論，讓觀眾知道下一步。
Bring questions about nutrition and medicines to qualified professionals and help viewers identify a next step.
OUR INTERNATIONAL COLLABORATION ROADMAP
從亞洲出發，連結全球夥伴。
Starting in Asia. Connecting with global partners.
我們正規劃分階段建立在地合作，邀請熟悉當地受眾、語言與服務需求的夥伴一起討論。
We are planning a phased approach to local partnerships and welcome conversations with partners who understand local audiences, languages and service needs.
- 01
亞洲優先市場
Initial Asian markets
台灣、中國、新加坡、香港、馬來西亞、印尼、菲律賓
Taiwan, China, Singapore, Hong Kong, Malaysia, Indonesia and the Philippines
- 02
中東市場
Middle East
阿聯酋（UAE）、沙烏地阿拉伯、卡達、阿曼
United Arab Emirates, Saudi Arabia, Qatar and Oman
- 03
歐洲與北美
Europe & North America
拓展歐洲，包括英國、愛爾蘭，並同步進入北美市場
Expand into Europe, including the United Kingdom and Ireland, alongside North America
以上為市場拓展規劃。產品供應、合作形式與服務內容，依各地條件及確認結果安排。
This is a market development plan. Product availability, partnership formats and services will depend on local requirements and confirmed arrangements.
洽談在地合作Discuss a local partnershipJOIN THE JOURNEY
一起把正確的衛教，帶給需要的人。
Help bring grounded education to people who need it.
網紅與內容創作者
Creators & influencers
希望用內容分享 442 與營養干預？提出你的受眾、平台與合作構想，一起討論合適的呈現方式。
Share your audience, platform and ideas for communicating 442 and nutritional intervention.
提出合作意向Share your interest經銷商與代理商
Distributors & agents
告訴我們所在市場與服務對象，討論產品、衛教素材及服務銜接的合作需求。
Tell us your market and audience to discuss product, education and service-coordination needs.
提出合作意向Share your interest志願者與社群支持
Volunteers & community support
希望參與糖友陪伴或衛教推廣？留下可投入的時間與希望參與的方式。
Tell us how you would like to contribute to community support or education, and your availability.
提出合作意向Share your interestSERVICE & BUSINESS MODEL
合作關係可以從單次服務，延伸為持續健康管理。
平台收入來自檢測協作與專業服務、180天個人化方案、年度會員服務，以及機構合作、聯合研發與授權。
Partnerships can grow from an initial service into ongoing health management.
The model combines testing collaboration and professional services, 180-day personalized programs, annual membership, institutional programs, joint R&D and licensing.
精準健康風險地圖
整合適用資料，建立管理優先序與專業溝通基礎。
Precision health risk map
Integrate relevant data into priorities and a foundation for professional discussion.
180天個人化方案
把風險轉成飲食、生活方式、植物營養及追蹤行動。
180-day personalized program
Turn risk into nutrition, lifestyle, botanical support and follow-up actions.
年度健康長壽服務
透過定期復評與長期資料持續調整下一階段。
Annual longevity service
Use reassessment and longitudinal data to refine each new stage.
醫療院所、健檢中心、研究團隊、製造與市場夥伴，都可以提出合作情境。
告訴我們服務對象、所在市場與希望解決的問題，團隊將依需求評估適合的起點。
Healthcare, screening, research, manufacturing and market partners can propose a collaboration scenario.
Tell us who you serve, your market and the problem you want to solve. The team will assess a suitable starting point.
07 · CONTACT
說說你的目標，
一起找到
適合的下一步。
Dibifree180® 減糖與減重方案、產品購買、衛教諮詢，以及內容推廣、經銷代理或志願者參與，都可以從這裡開始。
Tell us your goal.
Find your
next step.
Contact us for Dibifree180® glucose or weight support, product purchases, education, creator and distribution partnerships, or volunteering.
YOUR NEXT STEP
請留下需求與合作情境
描述越具體，我們越能安排適合的團隊成員與你聯繫。若涉及個人健康問題，請勿在表單填寫完整病歷或敏感醫療資料。
Tell us about your needs
Specific context helps us connect you with the right team member. For personal health inquiries, do not submit full medical records or sensitive health data in this form.
Dibifree180® / GLUCOSE
抗糖新觀念
Rethinking glucose care
從植物原料的研究出發，理解營養干預。
把配方依據、442 飲食與 180 天陪伴，接上每天的血糖照護。
Explore nutritional support through botanical research.
Connect formula evidence, 442 food guidance and 180 days of support with everyday glucose care.
BOTANICALS · MECHANISMS · EVIDENCE
植萃有依據
The science behind botanicals
抗糖，從看懂原料開始。
Understand the ingredients. Explore glucose care.
一餐之後，澱粉需要經過消化分解，才能以葡萄糖的形式被吸收。從消化這一步，到身體的血糖調節，植物原料研究探索著不同的作用方向。
After a meal, starch must be digested before it can be absorbed as glucose. Botanical research explores different steps, from digestion to the body’s regulation of blood glucose.
- 澱粉分解Starch digestion
- 糖類消化Carbohydrate breakdown
- 血糖調節Glucose regulation
以下先認識 Dibifree 已發表論文研究配方中的白腎豆與苦瓜。原料試驗各有萃取規格、用量及研究對象；整體配方的效果，另由 Dibifree 本身的研究評估。
Start with white kidney bean and bitter melon, listed in the published Dibifree study formulation. Ingredient trials use their own extracts, doses and populations; the complete formula is evaluated through Dibifree’s own research.
白芸豆
White kidney bean
研究澱粉分解
Studying starch digestion
白芸豆，又稱白腎豆。具 α-澱粉酶抑制活性的標準化萃取物，可影響澱粉分解。原料研究以此探索體重管理的可能性，作用與萃取物活性及用量有關。
White kidney bean extracts standardized for alpha-amylase inhibition can affect starch digestion. Ingredient studies explore this approach for weight management; activity and dose matter.
一項 12 週隨機試驗使用特定品牌萃取物並配合熱量限制飲食；研究結果應按該配方與條件解讀。
A 12-week randomized trial tested a specific branded extract alongside a calorie-restricted diet. Its findings apply to that formulation and those conditions.
苦瓜
Bitter melon
探索血糖調節
Exploring glucose regulation
苦瓜萃取物的研究關注血糖與升糖素等調節訊號。一項 12 週糖尿病前期成人試驗，觀察到萃取物組部分葡萄糖耐受測試指標下降。
Bitter melon extract studies examine blood glucose and regulatory signals such as glucagon. A 12-week trial in adults with prediabetes observed decreases in selected glucose-tolerance-test measures within the extract group.
這是特定苦瓜萃取物的研究；不同萃取物與苦瓜胜肽，需要各自對應的資料。
This trial studied a particular bitter melon extract. Other extracts and bitter melon peptides need their own supporting data.
回到每天的實踐：442 飲食、個別指導與 180 天追蹤，讓原料知識接上生活。442 依公司方針不納入澱粉；含澱粉試餐的原料研究，須按原試驗條件理解。
Connect ingredient knowledge with daily practice through 442 guidance, individual support and 180 days of follow-up. The company’s 442 approach excludes starchy foods; ingredient findings from starch-containing test meals must be interpreted in their original context.
了解實證醫學Explore the evidenceGLP-1 · NUTRITION · DAILY CARE
照護要跟上
Care that keeps pace
食慾變了，營養需求仍要被照顧。
Appetite changes. Nutritional needs still deserve attention.
為何不舒服
Why discomfort occurs
Semaglutide（如 Wegovy）會調節食慾並延緩胃排空。噁心、嘔吐、腹瀉或便秘是已知的腸胃副作用，常在開始治療或增加劑量時出現；口服與針劑都可能發生。
Semaglutide, including Wegovy, regulates appetite and delays gastric emptying. Nausea, vomiting, diarrhoea and constipation are known gastrointestinal effects, often appearing when treatment begins or doses increase. Both tablets and injections can cause them.
STEP 試驗的合併分析中，多數腸胃不適為輕至中度、暫時性；有些人仍可能出現較嚴重反應。
In a pooled STEP analysis, most gastrointestinal events were mild to moderate and transient, although some people can experience more serious reactions.
營養怎麼接
How nutrition fits
四個專業學會共同建議：GLP-1 治療期間應評估實際進食、營養是否足夠及腸胃耐受，並結合個別飲食、活動與持續支持。
Four professional societies recommend assessing food intake, nutritional adequacy and gastrointestinal tolerance during GLP-1 therapy, alongside individualized diet, activity and ongoing support.
Dibifree180® 的服務討論從餐食、用藥與生活紀錄開始，再與醫療團隊確認適合的營養安排。
A Dibifree180® consultation starts with meals, medicines and daily-life records, followed by discussion of an appropriate nutritional plan with the medical team.
先看耐受
Tolerance comes first
442 是公司的飲食方針。若使用 GLP-1 時有噁心、腹脹或進食困難，餐量、纖維與油脂安排需由醫師或營養師依耐受性調整。專業建議提到，治療初期可評估較小餐量、較頻繁進食，並避免高脂或高纖餐加重不適；不能直接套用固定比例來處理副作用。
442 is the company’s dietary approach. If GLP-1 treatment causes nausea, bloating or difficulty eating, a clinician or dietitian should adapt meal size, fibre and fat to tolerance. The advisory discusses smaller, more frequent meals and avoiding fatty or high-fibre foods early in treatment. A fixed ratio is not a treatment for side effects.
口服藥與補充品的服用間隔，請依所用藥品仿單向藥師確認。持續嘔吐、喝不下水或嚴重腹痛，請及時就醫。
Confirm oral medicine and supplement timing with a pharmacist using your medicine’s instructions. Seek prompt medical care for persistent vomiting, inability to keep fluids down or severe abdominal pain.
442 / FOOD EDUCATION
先學會選擇，再一起調整。
Learn the choices. Adjust together.
442 飲食方針不納入澱粉類食物。
The 442 approach excludes starchy foods.
膳食纖維
Dietary fibre
地瓜葉・苦瓜・秋葵・高麗菜
Sweet potato leaves · bitter melon · okra · cabbage
優質蛋白質
Quality protein
魚・肉・豆・蛋
Fish · meat · soy foods · eggs
好油
Good oils
橄欖油・酪梨油・苦茶油
Olive · avocado · camellia oils
依公司 442 飲食方針整理；個別食材選擇與實際份量，由衛教團隊協助確認。
Based on company education records and the confirmed approach. Percentages are not converted into calories, weight or plate area; discuss portions with the team.
DAILY SUPPORT
每一天，你與衛教團隊如何合作？
How do you work with the team each day?
記錄
Record
依團隊確認的方式記錄晨起與餐後血糖，餐前拍下三餐內容。
Record morning and post-meal glucose as agreed with your team, and photograph meals before eating.
回饋
Review
把照片與數據一起交給團隊，討論蔬菜、蛋白質、好油與執行困難。
Share photos and values to discuss vegetables, protein, oils and practical difficulties.
持續
Continue
按週追蹤體重，按團隊安排回顧檢驗；藥物調整由處方醫師評估。
Track weight weekly and review tests as arranged. Medication changes are assessed by your prescribing clinician.
180 DAYS / YOUR DAILY PRACTICE
有人陪你，把原則變成生活。
Support that turns principles into practice.
了解你的起點
Know your starting point
整理現有檢驗、用藥與生活情況，討論減糖或減重的個人目標。
Review existing tests, medications and daily life, then discuss personal glucose or weight goals.
把 442 放進每一天
Bring 442 into daily life
用三餐照片、血糖紀錄與體重追蹤，把飲食方針變成能持續的習慣。
Use meal photos, glucose records and weight tracking to build a repeatable routine.
30 天回看，持續調整
Review the first 30 days
回看資料是否完整、餐食是否適合、遇到哪些困難；記錄實際變化。
Review record completeness, meals and practical difficulties; document actual changes.
走到 180 天，也看下一步
Reach day 180 and plan ahead
依團隊安排定期回顧，於階段結束整理進度，討論接下來如何維持。
Review periodically with the team, assess progress at the end and discuss maintenance.
具體頻率與服務內容於諮詢確認。研究期程另見科研證據。
Confirm service scope and frequency during consultation. The clinical study has a separate timeline.
FROM OUR COMPANY MENUS
把原始菜單，帶進今天的備餐。
Bring the original menu ideas into today’s preparation.
花椰菜米搭配
Cauliflower-rice pairing
公司原始菜單：花椰菜米搭配蝦仁、鮭魚或碎牛肉，再安排蔬菜與好油。這裡的「米」是花椰菜，不是白米。
Original menu: cauliflower rice with shrimp, salmon or minced beef, alongside vegetables and good oils. “Rice” here refers to cauliflower, not grain.
蒟蒻麵搭配
Konjac-noodle pairing
公司原始菜單：蒟蒻麵搭配牛肉塊、豬肉片或綜合海鮮。依不納入澱粉的方針，選購時與團隊確認配料，避免混入一般麵粉或澱粉的產品。
Original menu: konjac noodles with beef, pork or seafood. Within the no-starchy-food approach, check ingredients with the team rather than using products mixed with ordinary flour or starch.
蔬菜與搭配
Vegetables and accompaniments
原始清單列有地瓜葉、芹菜、龍鬚菜、彩椒、大番茄、洋蔥、苦瓜，以及油醋醬；與蛋白質、好油一起規劃。
The original list includes sweet potato leaves, celery, chayote shoots, peppers, tomatoes, onions, bitter melon, and oil-vinegar dressing. Plan these with protein and good oils.
來源：公司《衛教 QA》原始工作簿，索引 20、39；食材與實際份量請依個人方案確認。
Source: company education Q&A workbook, indices 20 and 39. Confirm ingredients and portions within your individual plan.
第七版個人衛教紀錄；不作為 GLP-1 併用效果的證據。
A seventh-edition personal education account; this is not evidence of effects from co-use with GLP-1 treatment.
A RECORDED JOURNEY
第七版 No.7｜把運動從「知道」變成「做到」
Seventh edition No.7 | Turning knowledge into a routine
這位糖友原本不重視運動，也擔心糖尿病對日常生活的影響。參與衛教課程後，紀錄描述她開始使用跑步機，透過雲端回報接受持續輔導。
This participant had not made exercise a priority and was concerned about diabetes in daily life. The account describes starting treadmill activity after education sessions and receiving ongoing support through online reporting.
HbA1c：6.7% → 5.9%
2020/11/18 → 2021/06/30；七版第 25 頁計劃成果表。此處為第 7 個月的紀錄。
2020/11/18 → 2021/06/30; results table, p.25. The value shown is the month 7 record.
見證包含飲食、運動與其他照護的共同變化；不能由單一个案判定產品效果。
The account includes simultaneous changes in diet, activity and other care; one case cannot establish product efficacy.
REAL PEOPLE · 60 SECONDS
一分鐘見證
One-minute stories
你的經歷，值得被聽見。
Your experience deserves to be heard.
邀請分享 60 秒真實經歷：用藥背景、開始前後的感受與追蹤時間。影片會一併交代同期的用藥、飲食或活動變化。
Share a 60-second account covering treatment background, before-and-after experiences and follow-up time, alongside any changes in medicines, meals or activity.
個人經驗不能單獨證明產品降低副作用或預防復胖；影片內容須由本人確認並同意公開。
A personal account alone cannot establish that a product reduces side effects or prevents regain. Each contributor must confirm the content and agree to publication.
分享經歷Share your experience讓日常紀錄，與研究依據一起閱讀。
Read everyday records alongside the research.
Dibifree 的人體研究納入 40 位第二型糖尿病成人，研究期間為 7 個月。了解參與者、研究設計與結果，有助於判斷它對自己的意義。
The seven-month Dibifree study enrolled 40 adults with type 2 diabetes. Examine its participants, design and results to understand its relevance.
查看人體研究與期刊Explore the human study and paperGENINOVA · DIABETES & WEIGHT GENOMICS
糖尿與減重，
從理解差異開始。
Diabetes and weight.
Start with understanding.
整合家族史、代謝指標與生活紀錄，由專業評估決定基因檢測的角色，再連結個人化管理。
Combine family history, metabolic measurements and daily records to assess where genetic testing can inform personalized care.
適合先諮詢的情境
When to discuss testing
- 糖尿病家族史、年輕發病或分型疑問Family history, early-onset diabetes or uncertainty about diabetes type
- 體重管理需求，或疑似早發、遺傳性肥胖Weight-management needs or suspected early-onset genetic obesity
- 希望整合現有報告、生活習慣與醫療建議A need to connect existing reports, habits and clinical advice
YOUR SERVICE JOURNEY
從諮詢到追蹤，服務如何進行？
How does the service work?
由基諾華服務窗口協調，讓每一步都有清楚的銜接。
A Geninova service contact coordinates each stage.
- 01
諮詢與需求確認
Consultation
服務專員整理糖尿、體重與家族史問題。
A coordinator clarifies diabetes, weight and family-history concerns.
- 02
醫師評估
Clinical assessment
結合病史、血糖及代謝資料，決定是否檢測。
A clinician reviews history and metabolic data to assess testing value.
- 03
方案與採檢
Plan and collection
說明範圍、限制、費用與時程，完成同意後安排適用檢體。
Confirm scope, limitations, cost and timing before consent and suitable collection.
- 04
定序與專業判讀
Analysis and interpretation
依核定方案進行品質控管與分析，解釋結果及不確定性。
Perform agreed quality checks and analysis; explain results and uncertainty.
- 05
個人化方案
Personalized plan
醫師／營養師整合結果，討論藥物、營養、活動與合適的保健食品。
Clinicians integrate findings into medication, nutrition, activity and appropriate supplement guidance.
- 06
90／180天追蹤
90/180-day follow-up
追蹤執行情況與代謝變化，依醫療判斷調整。
Review implementation and metabolic trends; adjust with clinical guidance.
你會得到什麼？
What will you receive?
- 檢測範圍與檢前說明Testing scope and pre-test explanation
- 報告解讀與限制說明Report interpretation and limitations
- 個人化管理及追蹤方向Personalized management and follow-up direction
多久完成？費用如何計算？How long does it take, and what does it cost?
依檢測範圍、檢體品質與醫師安排，在確認方案時提供預估時程與費用。
Estimated timing and cost are provided when the scope, specimen and clinical arrangements are confirmed.
第一次諮詢需要準備什麼？What should I prepare for the first consultation?
先提供聯絡方式與想了解的項目即可。病歷、基因報告等敏感資料，請待專人說明安全交付方式。
Start with contact details and the service of interest. Wait for secure-transfer instructions before sharing records or genomic reports.
讓專人協助你確認下一步。
Let us help clarify your next step.
從需求開始，討論適合的評估與服務安排。
Start with your needs and discuss suitable assessment and service arrangements.
GENINOVA · IMMUNE DYSREGULATION GENOMICS
理解免疫失衡，
找到評估的下一步。
Understand immune imbalance.
Clarify the next step.
從反覆感染、發炎表現與家族史出發，協助專科醫師評估遺傳因素是否值得進一步檢查。
Start with infection patterns, inflammatory features and family history to support specialist assessment of possible genetic factors.
先釐清臨床問題，再決定檢測
Define the clinical question first
- 反覆或異常感染，已由醫師建議進一步評估Recurrent or unusual infections warranting specialist review
- 免疫失調或自體免疫表現合併遺傳性疾病疑慮Immune dysregulation with concern for an inherited condition
- 既有檢查尚未釐清，需整合家族與臨床資訊Unresolved findings requiring family and clinical context
YOUR SERVICE JOURNEY
從諮詢到追蹤，服務如何進行？
How does the service work?
由基諾華服務窗口協調，讓每一步都有清楚的銜接。
A Geninova service contact coordinates each stage.
- 01
服務諮詢
Consultation
先釐清就醫背景與檢測目的。
Clarify the clinical background and purpose of testing.
- 02
免疫專科評估
Specialist assessment
由專科醫師整合症狀、感染史與既有免疫檢驗。
A specialist reviews symptoms, infections and existing immune tests.
- 03
檢前說明與採檢
Consent and collection
依臨床問題確認檢測範圍與合適檢體。
Confirm an appropriate testing scope and specimen.
- 04
基因分析與判讀
Genetic analysis
將變異與臨床表現對照，說明致病性與證據限制。
Interpret variants against the clinical picture and strength of evidence.
- 05
報告諮詢與轉介
Review and referral
討論結果、不確定變異，以及是否需要遺傳諮詢或進一步檢查。
Discuss uncertain variants, genetic counseling and further evaluation where needed.
- 06
個人化追蹤
Individual follow-up
由醫師安排疾病追蹤；護理與服務團隊協助紀錄與聯繫。
The physician sets clinical follow-up; the service team supports records and coordination.
你會得到什麼？
What will you receive?
- 檢前資訊與檢體安排Pre-test information and collection planning
- 專業報告與結果諮詢Professional report and results consultation
- 專科銜接與追蹤建議Specialist coordination and follow-up advice
多久完成？費用如何計算？How long does it take, and what does it cost?
依檢測範圍、檢體品質與醫師安排，在確認方案時提供預估時程與費用。
Estimated timing and cost are provided when the scope, specimen and clinical arrangements are confirmed.
第一次諮詢需要準備什麼？What should I prepare for the first consultation?
先提供聯絡方式與想了解的項目即可。病歷、基因報告等敏感資料，請待專人說明安全交付方式。
Start with contact details and the service of interest. Wait for secure-transfer instructions before sharing records or genomic reports.
讓專人協助你確認下一步。
Let us help clarify your next step.
從需求開始，討論適合的評估與服務安排。
Start with your needs and discuss suitable assessment and service arrangements.
INDIVIDUAL CONTACT
個別諮詢
Individual inquiries
Dibifree180® / WEIGHT
減重智取勝
Smarter weight management
減下來的每一天，也為長期維持做準備。
從 GLP-1 治療到生活安排，讓營養、紀錄與陪伴一起接上。
Plan for long-term maintenance as you lose weight.
Connect GLP-1 care with nutrition, records and ongoing support.
WEIGHT LOSS · LONG-TERM CARE
減後怎麼走
What comes after weight loss
把長期維持，放進今天的計畫。
Make long-term maintenance part of today’s plan.
為何會回升
Why weight can return
停止治療後，藥物對食慾與飽足感的作用會消退；減重後的生理調節也可能增加飢餓感。體重管理因此需要長期安排，復胖不能只歸咎於意志力。
After treatment stops, the medicine’s effects on appetite and satiety fade. Biological adaptations after weight loss can also increase hunger, making long-term planning important; weight regain is not simply a matter of willpower.
Tirzepatide 是 GIP／GLP-1 雙重受體促效劑；其停藥研究也觀察到體重回升。不同藥物、劑量與族群的結果應分開解讀。
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Its withdrawal trial also observed weight regain. Results should be interpreted separately for each medicine, dose and population.
STEP 1 EXTENSION
約 2/3~2/3先前減掉的體重，在停用後一年平均回升。
Of prior weight loss was regained, on average, one year after withdrawal.
此延伸分析納入 327 位無糖尿病的過重或肥胖成人；第 68 週同時停止 semaglutide 2.4 mg 針劑與試驗生活介入。這是特定研究的平均結果，不是每個人的必然結局。
The extension included 327 adults with overweight or obesity without diabetes. Semaglutide 2.4 mg injections and the trial’s lifestyle intervention both stopped at week 68. This study average does not predict every person’s outcome.
劑量看醫囑
Dose decisions are clinical
Wegovy 等藥物的劑量與調整速度，依治療反應、耐受性及醫囑決定。把用藥與生活紀錄帶回診間，由處方醫師評估調整的時機與方式，讓營養照護與醫療安排相互銜接。
Dose and titration decisions for medicines such as Wegovy depend on response, tolerability and prescribing guidance. Bring medication and daily-life records to appointments so your prescriber can assess when and how to adjust treatment, alongside nutritional care.
把生活接上
Connect care with daily life
把進食狀況、蛋白質與水分、活動和體重趨勢帶進追蹤；在治療調整前，先與團隊談好後續安排。Dibifree180® 的營養支持可作為個別諮詢內容，讓營養安排與長期追蹤一起成為照護計畫的一部分。
Track intake, protein and hydration, activity and weight trends. Discuss follow-up before treatment changes. Explore Dibifree180® nutritional support in an individual consultation, connecting nutrition planning with long-term follow-up.
FIRST 30 DAYS
第一個月，看見自己的起點與進度。
Use the first month to establish your baseline and progress.
先留下起點
Record the baseline
整理體重、平日餐食、活動與正在使用的產品或藥物，先讓團隊了解你。
Share weight, usual meals, activity and current products or medicines so the team can understand your situation.
讓紀錄持續
Keep a weekly record
依原始衛教建議至少每週記錄體重，配合餐照回饋，檢查 442 是否落實。
The source guidance suggests at least weekly weight records, alongside meal-photo feedback and review of the 442 approach.
用實際資料回顧
Review actual progress
比較起點與目前紀錄，討論飲食和生活上的困難；以實際紀錄了解個人的進度。
Compare current records with your baseline and discuss dietary and lifestyle difficulties without a guaranteed kilogram target.
442 / NUTRITION
減重的日常，也從營養組成開始。
Build your weight-management routine around nutrition.
442 飲食方針不納入澱粉類食物。
The 442 approach excludes starchy foods.
膳食纖維
Dietary fibre
地瓜葉・苦瓜・秋葵・高麗菜
Sweet potato leaves · bitter melon · okra · cabbage
優質蛋白質
Quality protein
魚・肉・豆・蛋
Fish · meat · soy foods · eggs
好油
Good oils
橄欖油・酪梨油・苦茶油
Olive · avocado · camellia oils
依公司 442 飲食方針整理；個別食材選擇與實際份量，由衛教團隊協助確認。
Based on company education records and the confirmed approach. Percentages are not converted into calories, weight or plate area; discuss portions with the team.
180 DAYS / YOUR DAILY PRACTICE
有人陪你，把原則變成生活。
Support that turns principles into practice.
了解你的起點
Know your starting point
整理現有檢驗、用藥與生活情況，討論減糖或減重的個人目標。
Review existing tests, medications and daily life, then discuss personal glucose or weight goals.
把 442 放進每一天
Bring 442 into daily life
用三餐照片、血糖紀錄與體重追蹤，把飲食方針變成能持續的習慣。
Use meal photos, glucose records and weight tracking to build a repeatable routine.
30 天回看，持續調整
Review the first 30 days
回看資料是否完整、餐食是否適合、遇到哪些困難；記錄實際變化。
Review record completeness, meals and practical difficulties; document actual changes.
走到 180 天，也看下一步
Reach day 180 and plan ahead
依團隊安排定期回顧，於階段結束整理進度，討論接下來如何維持。
Review periodically with the team, assess progress at the end and discuss maintenance.
具體頻率與服務內容於諮詢確認。研究期程另見科研證據。
Confirm service scope and frequency during consultation. The clinical study has a separate timeline.
FROM OUR COMPANY MENUS
把原始菜單，帶進今天的備餐。
Bring the original menu ideas into today’s preparation.
花椰菜米搭配
Cauliflower-rice pairing
公司原始菜單：花椰菜米搭配蝦仁、鮭魚或碎牛肉，再安排蔬菜與好油。這裡的「米」是花椰菜，不是白米。
Original menu: cauliflower rice with shrimp, salmon or minced beef, alongside vegetables and good oils. “Rice” here refers to cauliflower, not grain.
蒟蒻麵搭配
Konjac-noodle pairing
公司原始菜單：蒟蒻麵搭配牛肉塊、豬肉片或綜合海鮮。依不納入澱粉的方針，選購時與團隊確認配料，避免混入一般麵粉或澱粉的產品。
Original menu: konjac noodles with beef, pork or seafood. Within the no-starchy-food approach, check ingredients with the team rather than using products mixed with ordinary flour or starch.
蔬菜與搭配
Vegetables and accompaniments
原始清單列有地瓜葉、芹菜、龍鬚菜、彩椒、大番茄、洋蔥、苦瓜，以及油醋醬；與蛋白質、好油一起規劃。
The original list includes sweet potato leaves, celery, chayote shoots, peppers, tomatoes, onions, bitter melon, and oil-vinegar dressing. Plan these with protein and good oils.
來源：公司《衛教 QA》原始工作簿，索引 20、39；食材與實際份量請依個人方案確認。
Source: company education Q&A workbook, indices 20 and 39. Confirm ingredients and portions within your individual plan.
第七版個人衛教紀錄；不作為 GLP-1 併用效果的證據。
A seventh-edition personal education account; this is not evidence of effects from co-use with GLP-1 treatment.
A RECORDED JOURNEY
第七版 No.6｜聚餐壓力，也需要有人一起面對
Seventh edition No.6 | Support through social-meal pressure
這位糖友曾習慣以含糖飲料代替水。見證描述他調整餐食，選擇蛋白質、纖維蔬菜與好油，同時由家人協助備餐、同伴互相鼓勵；也坦言朋友勸吃會影響執行。
This participant described a habit of sweet drinks, then changes toward protein, fibrous vegetables and good oils. Family meal preparation and peer encouragement helped, while social pressure remained a challenge.
體重自述：88 kg → 78 kgSelf-reported weight: 88 kg → 78 kg
自述為開始後兩個月的變化；七版第 23–24 頁。此為第二型糖尿病個案的經驗，個人結果不代表所有人的減重幅度。
Self-reported change over the first two months; pp.23–24. This is an account from a participant with type 2 diabetes, not an independent weight-loss trial or a one-month promise.
見證包含飲食、運動與其他照護的共同變化；不能由單一个案判定產品效果。
The account includes simultaneous changes in diet, activity and other care; one case cannot establish product efficacy.
REAL PEOPLE · 60 SECONDS
一分鐘見證
One-minute stories
你的經歷，值得被聽見。
Your experience deserves to be heard.
邀請分享 60 秒真實經歷：用藥背景、開始前後的感受與追蹤時間。影片會一併交代同期的用藥、飲食或活動變化。
Share a 60-second account covering treatment background, before-and-after experiences and follow-up time, alongside any changes in medicines, meals or activity.
個人經驗不能單獨證明產品降低副作用或預防復胖；影片內容須由本人確認並同意公開。
A personal account alone cannot establish that a product reduces side effects or prevents regain. Each contributor must confirm the content and agree to publication.
分享經歷Share your experience讓日常紀錄，與研究依據一起閱讀。
Read everyday records alongside the research.
Dibifree 的人體研究納入 40 位第二型糖尿病成人，研究期間為 7 個月。了解參與者、研究設計與結果，有助於判斷它對自己的意義。
The seven-month Dibifree study enrolled 40 adults with type 2 diabetes. Examine its participants, design and results to understand its relevance.
查看人體研究與期刊Explore the human study and paper